| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.54 | 0.002 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.45 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.42 | 0.0008 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.37 | 0.03 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.007 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.3 | 9e-09 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.29 | 1e-15 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |